Compare Viatris Inc (VTRS) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Viatris Inc vs Energy Select Sector SPDR Fund — how do they compare? Viatris Inc trades at $16.45 (market cap $19.09B), while Energy Select Sector SPDR Fund trades at $65.34. The key difference: Viatris Inc pays a 2.89% dividend while Energy Select Sector SPDR Fund pays none, and Energy Select Sector SPDR Fund is trading nearer its 52-week high, Viatris Inc nearer its low. Which is the better fit depends on your goals.
| VTRS | XLE | |
|---|---|---|
Market Cap | $19.09B | — |
Sector | Health | — |
52-Week High | $17.86 | $65.31 |
52-Week Low | $9.49 | $42.61 |
Enterprise Value | $31.21B | — |
Dividend Yield | 2.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Viatris (VTRS) trades at $16.61, down 1.6% over the past 24 hours. The stock exhibits a mixed technical picture with a bullish overall signal but bearish moving averages. Fundamentally, the company reported a net loss of $3.51 billion in 2025 despite revenue of $14.30 billion, though recent quarters have shown earnings beats. Positive cash flow generation and a dividend payment highlight financial stability, while analyst sentiment is mixed with a majority hold rating.
The outlook for VTRS hinges on its ability to return to profitability and sustain operational improvements. Investment opportunities include strong cash flow, deleveraging progress, and pipeline developments, but risks involve persistent net losses, competitive pressures, and potential regulatory impacts from proposed generic drug tariffs.
XLE trades at $64.78, up 1.12% with strong bullish technical signals from moving averages. The ETF benefits from oil price strength above $100/barrel and geopolitical tensions in the Middle East. Recent performance shows XLE gained 7.4% in August, leading sector ETFs. Technical indicators show RSI at 78.15 suggests overbought conditions while ADX indicates strong trend momentum.
Outlook remains positive given energy sector tailwinds from supply constraints and winter demand, though elevated oil prices create both opportunity and volatility risk. The ETF's concentrated holdings in major energy companies provide leveraged exposure to crude price movements, with valuations reflecting long-term oil prices below current spot levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
